Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 139700
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
GC Biopharma Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBIT
Data is available to registered users only
Target Price
The average target price of 006280.KS is 203841 and suggests 44% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Data is available to registered users only
Buy
Sell